Zobrazeno 1 - 10
of 96
pro vyhledávání: '"M Intorcia"'
Publikováno v:
Supportive Care in Cancer
Purpose Bisphosphonates and denosumab prevent bone complications in patients with bone metastases from solid tumours. This retrospective, longitudinal, cohort study provides data on their real-world use in this setting in Germany. Methods Adults with
Autor:
C Giannopoulou, Michele Cavo, Maria-Victoria Mateos, Niranchana Koneswaran, Daniela Niepel, Leah Fink, M. Intorcia
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BackgroundBone complications (pathologic fracture, spinal cord compression, surgery to bone and radiation to bone) are a common problem in patients with multiple myeloma (MM). We set out to provide insights into the real-world burden of bone complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e779ebb0fc4595964bb83224534f848c
http://hdl.handle.net/11585/804215
http://hdl.handle.net/11585/804215
Publikováno v:
Value in Health. 25:S23
Publikováno v:
Current Medical Research and Opinion. 35:513-523
Skeletal-related events (SREs), i.e. pathologic fractures, spinal cord compression, surgery and radiation to bone, are serious skeletal complications that occur frequently in patients with bone metastases (BMs) from solid tumors (STs). Clinical guide
Autor:
John Ashcroft, Ignacio Duran, Herbert Hoefeler, Marco Campioni, Amit Bahl, D Lueftner, M. Intorcia, Vito Lorusso
Publikováno v:
Ashcroft, J, Duran, I, Hoefeler, H, Lorusso, V, Lueftner, D, Campioni, M, Intorcia, M & Bahl, A 2018, ' Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma : Results from a prospective, multinational, observational study ', European Journal of Haematology, vol. 100, no. 5, pp. 479-487 . https://doi.org/10.1111/ejh.13044
Objectives: Patients with multiple myeloma (MM) often experience debilitating skeletal-related events (SREs: pathologic fracture, radiation to bone [RB], surgery to bone [SB] or spinal cord compression [SCC]). This is the first comprehensive, prospec
Autor:
Noopur Raje, Lisa Kennedy, Wolfgang Willenbacher, Garson David Roodman, Kazuyuki Shimizu, Guy Hechmati, Ramón García-Sanz, Evangelos Terpos, Lorenzo Sabatelli, M. Intorcia
Publikováno v:
Journal of Medical Economics. 21:525-536
A large, pivotal, phase 3 trial in patients with newly diagnosed multiple myeloma (MM) demonstrated that denosumab, compared with zoledronic acid, was non-inferior for the prevention of skeletal-related events (SREs), extended the observed median pro
Autor:
Rohini K. Hernandez, Yi Qian, Debajyoti Bhowmik, Christopher Bond, Steven Wang, Sam Colman, M. Intorcia, Paul Cheng
Publikováno v:
Cancer Medicine
Renal impairment is a common complication of multiple myeloma and deterioration in renal function or renal failure may complicate clinical management. This retrospective study in patients with multiple myeloma using an electronic medical records data
Publikováno v:
Journal of medical economics. 21(6)
To estimate incremental healthcare resource utilization (HRU) and costs associated with skeletal-related events (SREs) secondary to multiple myeloma (MM), and HRU and cost differences in patients with one vs multiple SREs.Adults with MM diagnosis bet
Publikováno v:
Value in Health. 22:S913-S914
Autor:
L. Karlsson, Oskar Ström, Jetty Overbeek, Maurille Feudjo Tepie, M. Intorcia, Johan Mesterton
Publikováno v:
Archives of Osteoporosis
Summary Using Swedish and Dutch registry data for women initiating bisphosphonates, we evaluated two methods of comparing the real-world effectiveness of osteoporosis treatments that attempt to adjust for differences in patient baseline characteristi